检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]上海交通大学医学院附属仁济医院头颈外科,上海200001
出 处:《中国眼耳鼻喉科杂志》2017年第3期170-175,共6页Chinese Journal of Ophthalmology and Otorhinolaryngology
摘 要:目的探讨人乳头瘤病毒(HPV)与喉鳞状细胞癌(LSCC)发生的关系以及HPV对LSCC患者预后的影响。方法回顾分析2004~2013年在本科就诊的252例LSCC患者的临床资料。所有手术标本为4μm厚切片,通过P16免疫组织化学染色及荧光定量聚合酶链反应(PCR)检测HPV的阳性率及分型。p16及HPV DNA同时阳性时认为HPV感染阳性。采用Kaplan-Meier法统计252例LSCC患者的总生存率及HPV阳性率对患者生存率的影响。结果 252例LSCC患者的P16阳性率为7.1%(18/252),HPV DNA的阳性率为6.0%(15/252),其中14例为HPV-16感染(93.3%),1例为HPV-18感染(6.7%)。252例LSCC患者的3年总生存率为67.0%,HPV DNA阳性患者的3年生存率为77.0%,HPV阴性患者的3年生存率为65.0%(P=0.25)。结论中国LSCC人群中HPV的阳性率较低。HPV感染与LSCC患者的预后无显著关系。Objective To determine whether human papillomavirus (HPV) infection is related to the prevalence and prognosis of laryngeal squamous cell carcinoma(LSCC). Methods A retrospective cohort study was applied on a total of 252 LSCC patients enrolled from 2004 to 2013. Paraffin-embedded tissues were cut as 4 μm slices. PI6 immunohistochemistry and fluorescence quantitation polymerase chain reaction (PCR) high risk HPV DNA tests were applied to detect the HPV infection status respectively in 252 specimens. Long-term survival rates were calculated using the Kaplan-Meier method. Results The p16 positive rate of all the patients was 7. 1% (18/252). Six percent (15/252) of LSCC patients were HPV DNA positive. All the HPV DNA positive patients were p16 positive, 93.3% (14/15) of the HPV DNA positive patients were HPV type 16 and the rest was HPV type 18. The 3-year overall survival rates were 67.0% for all 252 patients, 77.0% for HPV DNA positive patients, 65.0% for HPV DNA negative patients (P =0.25 ). Conclusions HPV has low prevalence in Chinese LSCC people. HPV infection status is associated with ISCC but may not be an available prognostic factor for [SCC. (Chin J Ophthalmol and Otorhinolaryngol,2017,17:170-175)
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.145